Medical Necessity: Unexplained Clinical Variation in Care

I am a physician who writes and edits guidelines designed to assist in determining appropriate utilization of clinical resources. In a nutshell, the issue that pertains to today’s topic, medical necessity, is “unexplained clinical variation in care.”

What I mean by that is the fact that patients with similar clinical features and issues are treated very differently depending on variables unrelated to severity of illness, risk of deterioration, or clinical need.

What varies is the amount or intensity of care (testing, inpatient hospital care, procedures, etc.). This variation is called “unexplained,” as it persists even after taking into account items such as patient age, socioeconomic status, and illness details.

Importantly, a consistent finding is that this variation in the intensity of care is not associated with improved patient outcomes. That is, despite general belief to the contrary, more care is not necessarily better care.

This sort of variation has been identified across all manner of clinical entities, treatments, and variables. Care provided varies rather profoundly, for example, by geographic region in the U.S.. In general, more care, and a higher intensity of care, is rendered in the Northeast than in the West, for example.

Furthermore, this variation can be found within geographic regions, according to physician specialty and practice location, and variation exists even within individual groups of physicians. For example, unexplained variation exists between hospitals in the same or similar settings, and between individual clinicians within a single hospital or practice. This variation is not random, in that the same geographic areas, specialties, and individual doctors are found to provide more resource-intensive care than their counterparts.

What sort of variation do I mean, and how does this relate to medical necessity?

Important aspects of care to measure include those decisions and interventions that carry high cost and potential for risk of harm. An early measure was inpatient length of stay. A more recent measure has been the inpatient admission rate. For example, patients seen in the emergency department for the same reason and with similar clinical features are admitted to the hospital for inpatient care at rates that can vary significantly.

The cost ramifications of the admission decision are straightforward. Less appreciated is the consistent finding that being a patient in a hospital is quite risky, and therefore should only be considered when the benefit (that is to say, need) clearly outweighs the risk of harm. Study after study has found that somewhere in the neighborhood of 4 percent of hospitalized patients experience a preventable harm (for example wrong medication, wrong dose, hospital-acquired infection, etc.).

With this background, the importance of medical necessity becomes clear. Simply leaving it up to individual clinicians has resulted in the variation seen. At the same time, it is in no way a simple matter to standardize which patients need which type or amount of care.

For unexplained clinical variation, an implemented response is the expectation that clinical decisions and interventions (or at the least, payment for these interventions) be justifiable, that is, defendable according to some mutually accepted standard (in other words, documentation of medical necessity).

Various clinical tools, such as the MCG evidence-based guidelines, have been used by involved parties (for example, payors and auditors) to assist in the determination of when the clinical documentation supports a defined threshold of “medical necessity.”

It is crucial that whatever standards are applied, they be clinically “right,” that is, neither overly strict nor lenient, and seen as unbiased by all parties involved. An important means by which to achieve this standard and level of acceptance is to be strictly evidence-based. This entails the difficult process of searching for the best evidence, expertly interpreting the evidence, and incorporating new evidence when appropriate.

Correct usage of guidelines is likewise important. For example, the MCG guidelines are intended to supplement and support clinician-based decision-making, not replace it. They are designed to be used as guidance, not interpreted as inflexible rules. Our guidelines are very specific and detailed when the medical literature allows, and at the same time acknowledging of the “gray areas” of decision-making when the evidence is not as clear.

In either case, the guideline content is used to not only set a standard for how to determine severity of illness or need for a procedure, but also to provide a common set of key moving parts within any given clinical situation that should be documented and described.

It is through this consistent, appropriate use of evidence-based guidelines that the central, chronic issue of unexplained clinical variation can be recognized and addressed. Identification, determination, and documentation of medical necessity are the active ingredients in any attempt to reduce unexplained clinical variation in care.

Facebook
Twitter
LinkedIn

Bill Rifkin MD, FHM, FACP

Dr. Bill Rifkin is the associate vice president and managing editor of MCG Health. Dr. Rifkin oversees all research and content published by MCG Health that is focused on acute inpatient care. His expertise expands to hospital medicine and clinical care, where he has published multiple research documents.

Related Stories

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

2026 IPPS Masterclass 3: Master MS-DRG Shifts and NTAPs

2026 IPPS Masterclass Day 3: MS-DRG Shifts and NTAPs

This third session in our 2026 IPPS Masterclass will feature a review of FY26 changes to the MS-DRG methodology and new technology add-on payments (NTAPs), presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 14, 2025
2026 IPPS Masterclass Day 2: Master ICD-10-PCS Changes

2026 IPPS Masterclass Day 2: Master ICD-10-PCS Changes

This second session in our 2026 IPPS Masterclass will feature a review the FY26 changes to ICD-10-PCS codes. This information will be presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 13, 2025
2026 IPPS Masterclass 1: Master ICD-10-CM Changes

2026 IPPS Masterclass Day 1: Master ICD-10-CM Changes

This first session in our 2026 IPPS Masterclass will feature an in-depth explanation of FY26 changes to ICD-10-CM codes and guidelines, CCs/MCCs, and revisions to the MCE, presented by presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 12, 2025

Trending News

Featured Webcasts

The Two-Midnight Rule: New Challenges, Proven Strategies

The Two-Midnight Rule: New Challenges, Proven Strategies

RACmonitor is proud to welcome back Dr. Ronald Hirsch, one of his most requested webcasts. In this highly anticipated session, Dr. Hirsch will break down the complex Two Midnight Rule Medicare regulations, translating them into clear, actionable guidance. He’ll walk you through the basics of the rule, offer expert interpretation, and apply the rule to real-world clinical scenarios—so you leave with greater clarity, confidence, and the tools to ensure compliance.

June 19, 2025
Open Door Forum Webcast Series

Open Door Forum Webcast Series

Bring your questions and join the conversation during this open forum series, live every Wednesday at 10 a.m. EST from June 11–July 30. Hosted by Chuck Buck, these fast-paced 30-minute sessions connect you directly with top healthcare experts tackling today’s most urgent compliance and policy issues.

June 11, 2025
Open Door Forum: The Changing Face of Addiction: Coding, Compliance & Care

Open Door Forum: The Changing Face of Addiction: Coding, Compliance & Care

Substance abuse is everywhere. It’s a complicated diagnosis with wide-ranging implications well beyond acute care. The face of addiction continues to change so it’s important to remember not just the addict but the spectrum of extended victims and the other social determinants and legal ramifications. Join John K. Hall, MD, JD, MBA, FCLM, FRCPC, for a critical Q&A on navigating substance abuse in 2025.  Register today and be a part of the conversation!

July 16, 2025

Trending News

Prepare for the 2025 CMS IPPS Final Rule with ICD10monitor’s IPPSPalooza! Click HERE to learn more

Get 15% OFF on all educational webcasts at ICD10monitor with code JULYFOURTH24 until July 4, 2024—start learning today!

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24